Boston Scientific Corp financial data

Symbol
BSX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
300 Boston Scientific Way, Marlborough, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 143 % +0.73%
Quick Ratio 51.1 % +4.91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.47B shares +2.26%
Entity Public Float 79B USD
Common Stock, Value, Issued 17M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.47B shares +2.27%
Weighted Average Number of Shares Outstanding, Diluted 1.48B shares +2.47%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.7B USD +12.7%
Operating Income (Loss) 2.47B USD +42.1%
Nonoperating Income (Expense) -317M USD -3.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.15B USD +50.4%
Income Tax Expense (Benefit) 377M USD -28.7%
Earnings Per Share, Basic 1.21 USD/shares +105%
Earnings Per Share, Diluted 1.19 USD/shares +102%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.33B USD +309%
Inventory, Net 2.56B USD +24.9%
Other Assets, Current 671M USD -5.63%
Assets, Current 8.19B USD +43.5%
Deferred Income Tax Assets, Net 3.79B USD -2.77%
Property, Plant and Equipment, Net 2.9B USD +16.9%
Operating Lease, Right-of-Use Asset 430M USD +7.77%
Intangible Assets, Net (Excluding Goodwill) 5.84B USD -3.65%
Goodwill 14.4B USD +8.23%
Other Assets, Noncurrent 1.6B USD +7.69%
Assets 36.7B USD +11.5%
Accounts Payable, Current 921M USD +6.11%
Employee-related Liabilities, Current 749M USD +13.3%
Accrued Liabilities, Current 2.08B USD +8.6%
Liabilities, Current 4.92B USD +20.4%
Long-term Debt and Lease Obligation 9.53B USD +12.2%
Accrued Income Taxes, Noncurrent 466M USD -23.4%
Deferred Income Tax Liabilities, Net 132M USD -37.1%
Operating Lease, Liability, Noncurrent 382M USD +6.11%
Other Liabilities, Noncurrent 1.92B USD -3.81%
Accumulated Other Comprehensive Income (Loss), Net of Tax 132M USD -25.8%
Retained Earnings (Accumulated Deficit) 1.31B USD
Stockholders' Equity Attributable to Parent 19.9B USD +11.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 20.2B USD +11.4%
Liabilities and Equity 36.7B USD +11.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 164M USD -13.7%
Net Cash Provided by (Used in) Financing Activities 1.57B USD
Net Cash Provided by (Used in) Investing Activities -285M USD +41.1%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 1.73B shares +1.91%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.44B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.5B USD +227%
Interest Paid, Excluding Capitalized Interest, Operating Activities 259M USD -42.4%
Deferred Tax Assets, Valuation Allowance 1.22B USD +21.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 3.71B USD -2.42%
Operating Lease, Liability 466M USD +14.2%
Depreciation 375M USD +10.6%
Payments to Acquire Property, Plant, and Equipment 179M USD +61.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.73B USD +101%
Lessee, Operating Lease, Liability, to be Paid 539M USD +9.55%
Property, Plant and Equipment, Gross 6.43B USD +10.1%
Operating Lease, Liability, Current 76M USD +24.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +30.3%
Deferred Income Tax Expense (Benefit) 73M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 74M USD -11.9%
Deferred Tax Assets, Operating Loss Carryforwards 744M USD +45.6%
Preferred Stock, Shares Issued 0 shares -100%
Deferred Federal Income Tax Expense (Benefit) -82M USD +10.9%
Current Income Tax Expense (Benefit) 320M USD -29%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 465M USD -7.19%
Operating Lease, Payments 93M USD +2.2%
Current State and Local Tax Expense (Benefit) 15M USD -21.1%
Current Federal Tax Expense (Benefit) 189M USD +271%
Amortization of Intangible Assets 839M USD +3.84%
Depreciation, Depletion and Amortization 304M USD +6.67%
Deferred Tax Assets, Net of Valuation Allowance 3.81B USD -3.57%
Deferred State and Local Income Tax Expense (Benefit) -22M USD +31.3%
Interest Expense 269M USD +5.08%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%